CGP-59326 is an epidermal growth factor receptor (EGFR) antagonist in the use of anti-cancer research. References: Torring N, Dagnaes-Hansen F, Sorensen BS, Nexo E, Hynes NE. ErbB1 and prostate cancer: ErbB1 activity is essential for androgen-induced proliferation and protection from the apoptotic effects of LY294002. Prostate. 2003 Jul 1;56(2):142-9. PubMed PMID: 12746839.

纯度：≥98%

CAS：173458-56-5